Biocontrol Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocontrol Inc.

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Craig Slotoroff who wrote ()	4/23/1996 10:06:00 PM
From: Peter Rice	of 100

Craig-Biocontrol submitted the Diasensor to an FDA panel in March for review & approval. Unfortunately the trial data was quite insufficient and the test group of subjects was minimal at best. Since then the company has agreed to re-run its testing of the Diasensor with the FDA aiding in the design of the program. If they do have a solid product the stock should do well with the FDA behind the test results. Another aspect of this company which you may not know about is their involvment with Hemocleanse. This is a technology which heats the blood of an Aids patient which in turn raises the core-body temperature to 108-109 degrees. This proceedure kills most of the Aids virus but does not cure the patient. In my opinion, this technology is the most dynamic part of the company. Bicocontrol holds the exclusive rights to this process for the use in Aids. Hope this is helpful.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext